On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair ... with the scientific team ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

So far this year, Eli Lilly (NYSE ... just yet if I were in Lilly's position. Ever feel like you missed the boat in buying ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight ... If you’re tired of feeling one step ...

Dreams of a tuition-free college education is closer than ever for five Ripley County students. The Lilly Endowment Community ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… ...

A Trinity Life Sciences report found that more pharma product launches were successful in 2023 than the year before. Here are ...

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...

Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

Despite the above, there are still a couple of silver linings that provide more than enough reason to be bullish about this stock.

Boise athletes won 20 of the 22 events at the 6A state meet. And the Southern Idaho Conference swept the team championships, ...